Inactive Instrument

Press Releases Champignon Brands Deutsche Boerse AG

Equities

496 CA15850D1006

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Braxia Scientific Announces Application for a Management Cease Trade Order For Late Filing of Audited Annual Financial Statements	07-15	NE
Braxia Scientific Reports Q3 2024 Financial Results	02-29	NE
Braxia Scientific Reports Mandatory Conversion of Debentures	01-15	NE
Braxia Scientific Reports Q2 2024 Financial Results and Provides Corporate Update	11-30	NE
Braxia Scientific : Reports a 26% Increase in Total Treatment Volumes in F2023 and an 87% Increase in Treatments at Newly Expanded Ottawa Clinic	23-07-31	PU
Braxia Scientific : Reports Fiscal 2023 Financial Results	23-07-31	PU
Irwin Naturals Inc.: Update on LOI for Business Combination with Braxia Scientific Corp.	23-03-21	AQ
Update on LOI for Business Combination with Braxia Scientific Corp.	23-03-20	AQ
Irwin Naturals Closes Acquisition of Leading Kentucky Clinic adding $3 Million in Projected EBITDA, Company delivering on ambitious strategy to build largest global network of mental health clinics	23-02-20	AQ
Braxia Scientific signs non-binding letter of intent to sell company to Irwin Naturals	23-02-07	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	23-01-30	AQ
Irwin Naturals Signs Letter of Intent to Acquire Braxia Scientific	23-01-27	AQ
Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US	23-01-10	AQ
Braxia Scientific Reports Q2 2023 Financial Results; Focused on Growing Clinic and Telemedicine Delivery of Novel Mental Health Treatments in North America	22-11-29	AQ
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers	22-10-04	AQ
Braxia Scientific Announces Board Appointment	22-09-21	AQ
Braxia Scientific to Present at H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022	22-09-09	AQ
Braxia Scientific Reports Q1 2023 Financial Results, Launches KetaMD in U.S. Increasing Treatment Access for Mental Health Patients	22-08-30	AQ
Braxia Scientific Enters U.S. Telemedicine Industry, Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	22-08-04	AQ
Braxia Scientific Enters U.S. Telemedicine Industry; Acquires KetaMD, a Mental Health Platform Providing Beneficial Ketamine Treatments in Florida with plans to expand across the U.S.	22-08-03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Champignon Brands Deutsche Boerse AG

Equities

496

CA15850D1006

Press Releases

Filters